Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

13.03
+0.02000.15%
Post-market: 12.95-0.0800-0.61%16:10 EDT
Volume:361.18K
Turnover:4.70M
Market Cap:1.37B
PE:-8.41
High:13.22
Open:13.11
Low:12.86
Close:13.01
Loading ...
Sep 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 14, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 24, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2022

Major Issues Report

8-K - Current report